These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 8311535)
1. Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients. Koh ET; Seow A; Ong B; Ratnagopal P; Tjia H; Chng HH Ann Rheum Dis; 1993 Dec; 52(12):857-61. PubMed ID: 8311535 [TBL] [Abstract][Full Text] [Related]
2. Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis. So MW; Koo BS; Kim YG; Lee CK; Yoo B J Rheumatol; 2011 Nov; 38(11):2432-5. PubMed ID: 21844145 [TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of 124 patients with polymyositis and dermatomyositis: Statistical analysis of prognostic factors. Ishizuka M; Watanabe R; Ishii T; Machiyama T; Akita K; Fujita Y; Shirota Y; Fujii H; Harigae H Mod Rheumatol; 2016; 26(1):115-20. PubMed ID: 26011440 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis of dermatomyositis and polymyositis: a study of 102 cases. Scola RH; Werneck LC; Prevedello DM; Toderke EL; Iwamoto FM Arq Neuropsiquiatr; 2000 Sep; 58(3B):789-99. PubMed ID: 11018813 [TBL] [Abstract][Full Text] [Related]
5. Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies. Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW Korean J Intern Med; 2021 Mar; 36(2):441-446. PubMed ID: 31875667 [TBL] [Abstract][Full Text] [Related]
6. Features of polymyositis and dermatomyositis in the elderly: a case-control study. Pautas E; Chérin P; Piette JC; Pelletier S; Wechsler B; Cabane J; Herson S Clin Exp Rheumatol; 2000; 18(2):241-4. PubMed ID: 10812498 [TBL] [Abstract][Full Text] [Related]
7. Polymyositis: an overdiagnosed entity. van der Meulen MF; Bronner IM; Hoogendijk JE; Burger H; van Venrooij WJ; Voskuyl AE; Dinant HJ; Linssen WH; Wokke JH; de Visser M Neurology; 2003 Aug; 61(3):316-21. PubMed ID: 12913190 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary involvement in polymyositis and in dermatomyositis. Marie I; Hatron PY; Hachulla E; Wallaert B; Michon-Pasturel U; Devulder B J Rheumatol; 1998 Jul; 25(7):1336-43. PubMed ID: 9676766 [TBL] [Abstract][Full Text] [Related]
9. Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study. Danieli MG; Gambini S; Pettinari L; Logullo F; Veronesi G; Gabrielli A Autoimmun Rev; 2014 Oct; 13(10):1048-54. PubMed ID: 25183232 [TBL] [Abstract][Full Text] [Related]
10. [Clinical analysis of pneumomediastinum complicated in polymyositis and dermatomyositis]. Tong SQ; Shi XH; Su JM; Zhao Y; Zhang FC Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):624-7. PubMed ID: 16681909 [TBL] [Abstract][Full Text] [Related]
11. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients. Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419 [TBL] [Abstract][Full Text] [Related]
12. An efficacy analysis of whole-body magnetic resonance imaging in the diagnosis and follow-up of polymyositis and dermatomyositis. Huang ZG; Gao BX; Chen H; Yang MX; Chen XL; Yan R; Lu X; Shi KN; Chan Q; Wang GC PLoS One; 2017; 12(7):e0181069. PubMed ID: 28715432 [TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients. Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort. Dobloug C; Garen T; Bitter H; Stjärne J; Stenseth G; Grøvle L; Sem M; Gran JT; Molberg Ø Ann Rheum Dis; 2015 Aug; 74(8):1551-6. PubMed ID: 24695011 [TBL] [Abstract][Full Text] [Related]
15. Prognosis and mortality of polymyositis and dermatomyositis patients. Airio A; Kautiainen H; Hakala M Clin Rheumatol; 2006 Mar; 25(2):234-9. PubMed ID: 16477398 [TBL] [Abstract][Full Text] [Related]
16. Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study. Ji SY; Zeng FQ; Guo Q; Tan GZ; Tang HF; Luo YJ; Tang ZQ; Han YF Chin Med J (Engl); 2010 Mar; 123(5):517-22. PubMed ID: 20367973 [TBL] [Abstract][Full Text] [Related]
17. Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study. Chen YJ; Wu CY; Shen JL Br J Dermatol; 2001 Apr; 144(4):825-31. PubMed ID: 11298544 [TBL] [Abstract][Full Text] [Related]
18. Malignancies in Korean patients with inflammatory myopathy. Lee SW; Jung SY; Park MC; Park YB; Lee SK Yonsei Med J; 2006 Aug; 47(4):519-23. PubMed ID: 16941742 [TBL] [Abstract][Full Text] [Related]
19. High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis. Maoz CR; Langevitz P; Livneh A; Blumstein Z; Sadeh M; Bank I; Gur H; Ehrenfeld M Semin Arthritis Rheum; 1998 Apr; 27(5):319-24. PubMed ID: 9572713 [TBL] [Abstract][Full Text] [Related]
20. Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options. Fredi M; Bartoli F; Cavazzana I; Ceribelli A; Carabellese N; Tincani A; Satoh M; Franceschini F Clin Exp Rheumatol; 2017; 35(2):303-308. PubMed ID: 27908312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]